Stryker vs. Zimmer Biomet vs. Johnson & Johnson: How they compare in Q4 2023

Stryker, Johnson & Johnson and Zimmer Biomet posted their fourth-quarter financial results for 2023 and data on their orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.8 billion (+11.8%)

Orthopedics: $2.4 billion (+11%)

Hips: $414 million (+10.2%)

Knees: $630 million (+14.2%)

Spine: $318 million (+7%)

Zimmer Biomet

Total sales: $1.9 billion (+6.3%)

Hips: $504.8 million (+3.3%)

Knees: $798.3 million (+5.9%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $453.3 million (+6.9%)

Johnson & Johnson

Total sales: $21.4 billion (+7.3%)

Spine, sports and other: $742 million (+6.2%)

Orthopedic: $2.3 billion (+5.6%)

Hips: $398 million (+3.4%)

Knees: $387 million (+9.2%)

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.